Rezolute advances HI drug trial after DMC review and secures $90 million in funding through stock offering to support ...

Rezolute (RZLT) announced the DMC’s recommendation to continue the Phase 3 sunRIZE study as planned in patients with congenital HI, without an ...

Rezolute shares were up 29%, to $4, after the company said an independent data monitoring committee recommended the continuation of a Phase 3 Ersodetug study in patients with congenital ...

The Chiefs’ first-round options hinge on the outcome of the 30 preceding selections. Here’s how they could throw KC an early ...

Journalists’ privilege also shows in their schooling. Twenty-two percent of journalists in our sample attended a fee-paying ...

A group of campaigners in the United States has said “essential” data from the American Community Survey – used to allocate ...

Every first overall draft pick is by definition a statistical anomaly. But even among that rare crop of talent, Ward’s ...

Through five starts, the 31-year-old has a 6.43 ERA and 1.61 WHIP with 34 hits allowed and a 31:11 K:BB ratio in 27 innings.

Unlike statistical tools, which are grounded in rigorous mathematical frameworks and can be audited, LLMs are inherently ...

Although the political party Isamaa remains the most popular, its support dropped by 1.5 percentage points over the past week ...

Green Bay, the smallest market in the National Football League, is ready to host one of the league's biggest events — the ...